Three capabilities your clinical lead signs off on — between-dose monitoring, medication-adherence continuity, and overnight escalation routing.
Every Embertide deployment at an outpatient MAT/OAT clinic runs as an adjunct to the clinic’s existing operations. The watch starts at induction, the adherence signal lands before the refill appointment, and the read-back arrives at the next clinical touchpoint informed by what actually happened — your prescribing team, nurse line, and 24/7 crisis-line partners stay where they are.
- 01After-visit watch
The watch starts the moment your patient leaves induction
Embertide starts a daily check-in the day your patient is discharged from induction — between induction and the next refill visit, the watch is on. Daily check-ins, peer-chat tone, and missed-touch patterns fuse into one rising-risk surface per member, so the day-7-to-day-21 window between visits is a watched window rather than an unmonitored stretch.
- 02Adherence + early-warning
Buprenorphine / methadone adherence surfaced before the refill visit
When a patient's daily touchpoints start to drift, when the peer-chat tone turns short, or when the rising-risk window opens ahead of the next clinical touchpoint, Embertide surfaces it — earlier than the refill appointment would catch it. Adherence is read from the watch, not from pill counts at the next visit three weeks later.
- 03Read-back to the clinic
The watch hands the trajectory back to your team at the next visit
At the next clinical touchpoint, your team reads the trajectory your patient lived through the past three weeks — the rising-risk windows, the peer-chat tone shifts, the missed-touch days — so the conversation at the refill visit is informed by what actually happened, not by what the patient remembers to report.
The watch, the score, and the routing tiers — including where your clinic’s nurse line fits — are laid out in plain language on Read the full /how-it-works explainer →
The questions an outpatient MAT/OAT clinic director actually asks before scoping a pilot.
These are the questions we hear from clinical directors, intake leads, and compliance officers in procurement scoping. Every answer below is a feature, not a workaround — designed so the watch bridges between visits without changing how your clinic prescribes or dispenses.
Still have one we missed? Send the question.
See how Embertide bridges between visits at your clinic.
Send your monthly induction volume, your MOUD mix (buprenorphine / methadone / naltrexone), and a short note on the nurse line routing you’d want configured into the cascade — we’ll come back with a 90-day pilot scope and the read-back trajectory your prescribing team will see at the next refill visit.
Running this for a treatment-center network instead? See treatment-center program →
Scoping this for a state Medicaid program instead? See state Medicaid program →
Bridging between visits from a peer-recovery-provider perspective? See peer-recovery organizations program →
What to send
- · Monthly induction volume at your clinic
- · Your MOUD mix (buprenorphine / methadone / naltrexone)
- · Your current nurse-line routing
- · 90-day read-back metric your team will measure against
Tell us about your clinic’s induction volume and MOUD mix.
We'll read your message within one business day and come back with a 90-day pilot scope — including the read-back trajectory your prescribing team will see at the next refill visit, and the cascade routing that hands off into your own nurse line.
Prefer email? Reach us at embertide-2@polsia.app.
Looking for the family-member side instead? See /for-families →
Scoping this for a state Medicaid program instead? See state Medicaid program →
Running a treatment-center network instead? See treatment-center program →
Running this for a peer-recovery provider instead? See peer-recovery organizations program →